Stockreport

Pasithea Therapeutics Harnessing Ketamine for Psychiatric Treatment of Depression

Pasithea Therapeutics Corp.  (KTTA) 
PDF MIAMI BEACH, Fla. (PRWEB) November 24, 2021 A new biotech company is partnering with I.V. Doc® to bring in-home psychiatric ketamine treatments for depression across th [Read more]